SVB Financial Group Files For Mixed-Securities Shelf Offering, Size Not Disclosed

-SEC Filing

byMichael Horton

March 2, 2023

1 minute read

-SEC Filing

BCE Clocks 3.2% Revenue Growth In Q3 Backed By Wireless, Residential Internet Growth

By Anusuya Lahiri

November 3, 11:27 AM

BCE, Inc (NYSE: BCE) reported third-quarter FY22 operating revenue growth of 3.2% year-on-year to CA$6.02 billion. The company attributed the performance…

BCE

Events
News

Merck Announced Adjuvant Treatment With KEYTRUDA (pembrolizumab) Demonstrates Statistically Significant & Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients With Resected Stage IIB or IIC Melanoma in Phase 3 KEYNOTE-7…

By Charles Gross

June 5, 8:42 AM

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced distant metastasis-free survival (DMFS) results from the Phase 3 KEYNOTE-716 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, versus placebo as adjuvant therapy for patients with resected stage IIB or IIC melanoma.

MRK